Xenetic Biosciences, Inc. revenue breakdown overview

Xenetic Biosciences, Inc. revenue for the last year amounted to 2.50 M USD, the most of which — 2.50 M USD — came from its highest performing source at the moment, Immune-oncology Technologies, the year earlier bringing 2.54 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Xenetic Biosciences, Inc. 2.50 M USD, and the year before that — 2.54 M USD.